Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24Urinary Bladder Neoplasms 5Neoplasms 2Urothelial Bladder Cancer 1Urologic Neoplasms 1Urinary Bladder Diseases 1Stomach Neoplasms 1Recurrence 1Prostate cancer, familial 1Parotid Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Lung Neoplasms 1Genetic Predisposition to Disease 1Driving Under the Influence 1Disease Progression 1Disease 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 3Interviews as Topic 3Specimen Handling 2Blood Specimen Collection 2posaconazole 1liposomal doxorubicin 1Vinorelbine 1Sequence Analysis, RNA 1Sequence Analysis, DNA 1Prophylactic Mastectomy 1Phlebotomy 1Mutation 1Multiparametric Magnetic Resonance Imaging 1Minoxidil 1Magnetic Resonance Spectroscopy 1High-Throughput Nucleotide Sequencing 1Genome-Wide Association Study 1Genetic Testing 1Fluconazole 1Exome 1Docetaxel 1Demography 1DNA 1Cognitive Behavioral Therapy 1Cephalexin 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Predisposition to Disease × Multiparametric Magnetic Resonance Imaging × Clear all
NCT05681416 2023-01-12

ProFam-Risk

Heinrich-Heine University, Duesseldorf

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡